Results 261 to 270 of about 4,391,625 (378)

Synaptopodin is required for long-term depression at Schaffer collateral-CA1 synapses. [PDF]

open access: yesMol Brain
Inglebert Y   +4 more
europepmc   +1 more source

Long-term depression: a cell biological view

open access: yesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2014
Morgan Sheng, Ali Ertürk
semanticscholar   +1 more source

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

open access: yesAdvanced Therapeutics, EarlyView.
This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar   +7 more
wiley   +1 more source

Disruption of Long-Term Depression Potentiates Latent Inhibition: Key Role for Central Nucleus of the Amygdala. [PDF]

open access: yesInt J Neuropsychopharmacol, 2021
Ashby DM   +5 more
europepmc   +1 more source

The Maudsley long-term follow-up of child and adolescent depression [PDF]

open access: bronze, 2002
Martín Knapp   +4 more
openalex   +1 more source

NAD+‐Boosters Improve Mitochondria Quality Control In Parkinson's Disease Models Via Mitochondrial UPR

open access: yesAdvanced Science, EarlyView.
Treatment of MPTP‐incubated cells with NAD+‐boosters increase the UPRmt/mitophagy‐related mitochondria quality control (MQC). Disturbed plasma UPRmt‐mitophagy‐mediated MQC profiles in PD patient samples. NMN inhibits motor deficit and forestalls neuropathology phenotypes of PD mice, which is required the atf4‐medicated UPRmt pathway.
Shuoting Zhou   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy